Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral

Pranati Das1, Ajay Amit1, Shubhankar Kumar Singh1

  • 1Division of Immunology, Rajendra Memorial Research Institute of Medical Sciences, Agamkuan, Patna, Bihar, 800007India.

Parasitology International
|September 17, 2014
PubMed

Insights

Leishmania proteins pp63, pp41, and pp29 show promise in combating leishmaniasis. Vaccination with these proteins reduced parasite load and anemia in mice, indicating potential therapeutic applications.

Area of Science:

  • Immunology
  • Parasitology
  • Molecular Biology

Background:

  • Leishmania virulence and survival are linked to phosphoproteins.
  • Leishmania inhibits macrophage functions via interference with signaling pathways.
  • Specific Leishmania proteins (pp63, pp41, pp29) are Th1 stimulatory.

Purpose of the Study:

  • To assess the immunogenicity of a cocktail of Leishmania proteins pp63, pp41, and pp29.
  • To evaluate the protective effects of these proteins against Leishmania donovani infection in mice.

Main Methods:

  • Immunization of mice with individual proteins and a cocktail.
  • Measurement of serum antibody titers.
  • Assessment of nitric oxide (NO) production by splenocytes.
  • Quantification of Th1 (IFN-γ) and Th2 (IL-4) cytokines.
  • Determination of parasite load in liver and spleen.
  • Monitoring of hematological profiles.

Main Results:

  • A significant rise in antibody titer was observed post-immunization.
  • Vaccination led to a substantial increase in NO production.
  • Immunized groups showed reduced parasite burden in liver and spleen.
  • Increased production of IFN-γ was noted in spleen cells.
  • Hematological profiles remained normal in immunized mice, unlike anemic controls.

Conclusions:

  • The Leishmania proteins pp63, pp41, and pp29, individually and as a cocktail, elicit a protective immune response.
  • This immune response is characterized by increased NO production, Th1 cytokine release, and reduced parasite load.
  • The tested proteins demonstrate potential as vaccine candidates against Leishmania donovani infection.

Related Concept Videos